B.Riley on WAVE Life Sciences (WVE): 'a ~60% intraday selloff that, in our view, is significantly overdone'
Tweet Send to a Friend
B.Riley analyst Madison El-Saadi reiterated a Buy rating and $37.00 price target on WAVE Life Sciences (NASDAQ: WVE).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
